-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
LIPELLA PHARMACEUTICALS INC. quarterly/annual Operating Income (Loss) history and change rate from 2021 to Q3 2025.
- LIPELLA PHARMACEUTICALS INC. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$1.27M, a 12.7% increase year-over-year.
- LIPELLA PHARMACEUTICALS INC. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$5.41M, a 24.1% decline year-over-year.
- LIPELLA PHARMACEUTICALS INC. annual Operating Income (Loss) for 2024 was -$5.08M, a 7.05% decline from 2023.
- LIPELLA PHARMACEUTICALS INC. annual Operating Income (Loss) for 2023 was -$4.75M, a 83.3% decline from 2022.
- LIPELLA PHARMACEUTICALS INC. annual Operating Income (Loss) for 2022 was -$2.59M, a 35.2% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)